Dicarba-closo-dodecaboranes as a pharmacophore. Retinoidal antagonists and potential agonists

Chem Pharm Bull (Tokyo). 1999 Mar;47(3):398-404. doi: 10.1248/cpb.47.398.

Abstract

Synthesis and biological evaluation of the first dicarba-closo-dodecaborane (carborane) derivatives of retinoids are described. Their retinoidal activity were examined in terms of the differentiation-inducing ability toward human promyelocytic leukemia HL-60 cells. High retinoidal activity (agonist or antagonist for retinoic acid receptor (RAR) requires a carboxylic acid moiety and an appropriate hydrophobic group located at a suitable position on the molecule. The 4-carboranyl-substituted compounds (7, 11) showed antagonistic activity but no agonistic activity even in the presence of the potent synergist HX630. On the other hand, the 3-carboranyl-substituted compounds (8, 12) showed potential agonistic activity, but no antagonistic activity. The results indicates that carboranes are applicable as the hydrophobic moiety of biologically active molecules.

MeSH terms

  • Boron Compounds / chemical synthesis*
  • Cell Differentiation / drug effects
  • Granulocytes / drug effects
  • HL-60 Cells
  • Humans
  • Receptors, Retinoic Acid / agonists*
  • Receptors, Retinoic Acid / antagonists & inhibitors*
  • Retinoids / chemical synthesis*

Substances

  • Boron Compounds
  • Receptors, Retinoic Acid
  • Retinoids